The accurate measurement of in vivo prostate volume has gained greater importance with the development of prostate brachytherapy. Prostate brachythera

Size: px
Start display at page:

Download "The accurate measurement of in vivo prostate volume has gained greater importance with the development of prostate brachytherapy. Prostate brachythera"

Transcription

1 Note: This copy is for your personal non-commercial use only. To order presentation-ready copies for distribution to your colleagues or clients, contact us at Peter J. MacMahon, MRCPI Ann-Marie Kennedy, MSc Darra T. Murphy, MRCPI Michael Maher, FFR, RCSI Michelle M. McNicholas, FFR, RCSI, FRCR Modified Prostate Volume Algorithm Improves Transrectal US Volume Estimation in Men Presenting for Prostate Brachytherapy 1 Purpose: To evaluate the accuracy of the conventional transrectal ultrasonographic (US) prostate volume formula and determine whether a more accurate volume formula, calculated on the basis of prostate shape as observed at planimetry, can be described for the majority of prostate glands. ORIGINAL RESEARCH ULTRASONOGRAPHY 1 From the Department of Radiology, Mater Misericordiae University Hospital, Eccles Street, Dublin 7, Ireland (P.J.M., D.T.M., M. M. McNicholas); and Department of Radiotherapy, Mater Private Hospital, Dublin, Ireland (A.M.K., M. Maher). From the 2007 RSNA Annual Meeting. Received February 12, 2008; revision requested March 28; revision received June 25; accepted July 7; final version accepted July 30. Address correspondence to M. M. McNicholas ( michelle.mcnicholas@nbsp.ie ). Materials and Methods: Results: Conclusion: This retrospective study was institutional review board approved, with waiver of informed consent. A total of 138 consecutive patients who underwent prostate brachytherapy were included for analysis. Prostate volume was estimated by using the conventional prolate ellipsoid formula (length height width [ /6]). A reference standard for prostate volume was calculated by using planimetry. The mean prostate shape was assessed by using three-dimensional volume-rendering of the planimetric images. The prostate shapes were evaluated to determine the best-fit mathematic formula for accurate volume estimation. Statistical analyses were performed by using Pearson correlation, paired Student t test, Bland-Altman plots, and concordance correlation coefficient. Planimetric data showed the majority of prostate glands to be more bullet-shaped than ellipsoid. Only 13.3% of volumes determined by using the conventional prolate ellipsoid formula were within 10% of the planimetric volume. The prolate ellipsoid formula underestimated volume by 17% on average (95% confidence interval: 14%, 19%). A mathematic formula representing a bullet shape (length height width [ /4.8]) was determined to best represent the majority of prostate glands presented for brachytherapy; 75% of volumes were within 10% of planimetric volume by using this formula. Concordance correlation coefficient increased from 0.87 to Formula accuracy was particularly improved in prostate glands smaller than 55 cm 3 (P.14). A modified prostate volume formula that closely represents the shape of the prostate smaller than 55 cm 3 demonstrated improved volume measurement accuracy compared with the prolate ellipsoid formula used in men presenting for brachytherapy. RSNA, 2009 RSNA, 2009 Radiology: Volume 250: Number 1 January

2 The accurate measurement of in vivo prostate volume has gained greater importance with the development of prostate brachytherapy. Prostate brachytherapy is a form of radiation therapy where radioactive sources (seeds) are placed percutaneously by using a transperineal approach to the prostate gland under ultrasonographic (US) guidance to treat early prostate cancer. Patient selection for such therapy is dependent on the size of the prostate gland. Patients with large glands are frequently unsuitable for brachytherapy for technical reasons and because of an increased side-effect profile (1). Technical problems are largely a result of pubic arch encroachment over the prostate gland, and a cutoff size of 50 cm 3 is generally employed. Furthermore, in most cases, the radioactive seeds must be ordered in advance, and the number of seeds ordered is determined on the basis of the outpatient gland volume measurement. Recently, prostate-specific antigen density has been found to be a significant predictor of adverse pathologic features and biochemical recurrence in prostate cancer (2). It is calculated by dividing the serum prostate-specific antigen level by the prostate volume. Hence, it is dependent on accurate prostate volume measurement. Conventionally, the prostate gland volume is assessed as an outpatient procedure at the time of transrectal USguided biopsy retrieval by measuring three gland dimensions: the maximum length (L), the maximal height orthogonal to the length (H), and the maximal width (W). The volume is then calculated by using the prolate ellipsoid formula: length height width [ /6] (3). Advance in Knowledge A modified prostate volume algorithm, which describes a bulletshaped prostate gland, as opposed to the conventional prolate ellipsoid shape, significantly improves volume measurement accuracy in men presenting for prostate brachytherapy. The number of radioactive seeds placed at brachytherapy is critically dependent on the prostate volume (4). The seeds must also be implanted accurately in a distribution that optimizes radiation dose, while avoiding overexposure of critical structures such as the urethra and rectum. Therefore, immediately prior to brachytherapy the prostate volume is accurately measured by using a planimetric transrectal US stepping method, which is considered the reference standard for measuring the prostate volume in vivo. Our prostate brachytherapy patients are predominately referred from outside institutions, having already undergone prostate volume estimation at the referring institution. We have noted a discrepancy between the outpatient transrectal US measurements and our prebrachytherapy planimetric measurement. This has, on occasion, led to termination of the brachytherapy procedure after the patient has received a general anesthetic, owing to the actual volume being too large for brachytherapy treatment. Apart from unnecessary exposure to general anesthetic and patient disappointment at the abandonment of the chosen form of treatment, there is also waste of the expensive radioisotope sources, which rapidly lose their optimum activity (5). An improvement in prostate volume estimation would also allow improved accuracy for prostate-specific antigen density measurements. Our purpose is to evaluate the accuracy of the conventional transrectal US prostate volume formula and determine whether a more accurate volume formula, calculated on the basis of prostate shape as observed at planimetry, can be described for the majority of prostate glands. Implication for Patient Care The current inaccurate method of prostate estimation can be improved simply and significantly, thus reducing inappropriate patient selection for prostate brachytherapy. Materials and Methods Patients Institutional ethics committee approval was obtained for this retrospective study, with waiver of informed consent. All patients referred for prostate brachytherapy as a treatment for localized prostate cancer in the last 2 years at our institution were included for analysis. All patients had been assessed as outpatients for an increased prostate-specific antigen level ( 4 ng/ml [ 4 g/l]). Patients were diagnosed with prostate carcinoma after transrectal US-guided core biopsy. All patients were staged as having localized disease and were suitable for iodine 125 brachytherapy. Sixty patients were retrospectively analyzed to assess accuracy of outpatient volume estimation by using the conventional prolate ellipsoid formula by comparing it with the volume calculated by using the planimetric stepping method. An analysis was made to determine the shape of the majority of glands and to derive a best-fit mathematic formula on the basis of the observed shape. Subsequently, the next 78 patients referred for brachytherapy were assessed by comparing the volume calculated in two methods from the same data set: by using the conventional prolate ellipsoid formula and by using a mathematic formula given the observed shape. The reference standard for prostate volume measurement was obtained at the time of brachytherapy by using a planimet- Published online /radiol Radiology 2009; 250: Author contributions: Guarantors of integrity of entire study, P.J.M., M. McNicholas; study concepts/study design or data acquisition or data analysis/interpretation, all authors; manuscript drafting or manuscript revision for important intellectual content, all authors; approval of final version of submitted manuscript, all authors; literature research, all authors; clinical studies, all authors; statistical analysis, P.J.M.; and manuscript editing, all authors Authors stated no financial relationship to disclose. 274 Radiology: Volume 250: Number 1 January 2009

3 ric stepping method, as described below. The actual outpatient transrectal US prostate volumes were not included for analysis as these data were obtained by several radiologists working at several institutions by using a variety of US equipment and uncertain techniques. All measurements were obtained from a single US machine (EUB 5500; Hitachi Medical, Tokyo, Japan), with an 8-MHz side-firing biplanar transrectal probe (EUP-U533; Hitachi Medical, Tokyo, Japan). This biplane probe incorporates both side-firing radial and linear mutually perpendicular transducers. The patient was placed on a table in the dorsolithotomy position and legs placed in stirrups. The reference prostate volume was computed with planar measurements obtained by using 5-mm step sections with the probe mounted in a stepping device (EXII; CIVCO, Kalona, Iowa). The circumference of each prostate image was traced by a staff radiologist (M. M. McNicholas, with 15 years experience in prostate imaging). The US software computed the volume from the measurements of each section (Variseed, version 7.1; Varian Medical Systems, Charlottesville, Va). The three prostate dimensions (length, height, and width) used in the prolate ellipsoid formula were measured independently by three radiologists (P.J.M., D.T.M., and M. M. McNicholas, each with 2 15 years experience) on the US images obtained at planimetry. The maximal length, the maximal height measured orthogonal to the sagittal length, and the maximal width were measured by using the images reconstructed from planimetric data. The conventional transrectal US volume estimation was calculated by using the prolate ellipsoid formula. This conventional volume calculation was compared with the reference standard volume as assessed at planimetry. Shape Analysis The prostate glands in the initial cohort of 60 patients were volume rendered in three dimensions by the planimetry software (Fig 1a) and visual assessment of the rendered prostate shape was performed (Fig 2a). To establish the optimal volume formula, various geometric three-dimensional shapes (ie, prolate ellipsoid, cylinder, cube, and cone) were combined in an effort to replicate the rendered prostate shape. Mathematic formulas were derived for each shape that could be simplified to a three-dimensional planar measurement technique (length height width). Shape combinations that were assessed included: one-half ellipsoid plus cone, one-half ellipsoid plus cube, two-thirds ellipsoid plus cylinder, two-thirds ellipsoid plus cone, one-third ellipsoid plus cylinder, and one-third ellipsoid plus Figure 1 cube. For each combination, a single mathematic volume formula was derived and compared with the reference data set by using the statistical tests described below. A single three-dimensional shape composed of a cylinder and one-half of a prolate ellipsoid (a bullet shape [Fig 2b]) demonstrated the closest statistical concordance and is presented here. We observed this to be the case for glands of up to about 55 cm 3 in volume. Above this volume, we observed that the shape of the glands was more unpredictable. The bullet formula for determining Figure 1: (a) Sample of volume-rendered US images of prostate glands measuring less than 55 cm 3 from initial patient cohort. (b) Prostate glands more than 55 cm 3 have unpredictable shapes secondary to asymmetric lobar enlargement. Figure 2 Figure 2: (a) Three-dimensional rendering of prolate ellipsoid shape assumed for prostate to use with conventional volume formula. (b) New bullet shape combines cylinder and one-half prolate ellipsoid. Radiology: Volume 250: Number 1 January

4 prostate shape was then assessed in the next 78 patients referred for brachytherapy to validate accuracy. Most (55 of 60) of these patients had glands that were less than 55 cm 3 ; a volume of less than 50 cm 3 at outpatient transrectal US was one of the referral criteria. Statistical Analysis We examined the correlation between prolate ellipsoid volumes and planimetry by using the Pearson correlation coefficient, paired t test, linear regression, and Bland-Altman plots (6,7). We additionally used the concordance correlation coefficient as a method to compare two measurements (8). Interobserver reliability was demonstrated by using linear regression, Bland-Altman plots, and concordance correlation. Results The mean prostate volume, as calculated by using the conventional prolate ellipsoid formula with planimetric data sets in the initial 60 patients, was cm (standard deviation) (range, cm 3 ). The reference standard volume calculated by using the stepping method was cm (range, cm 3 ). The mean difference between techniques was 5.87 cm 3 (95% confidence interval: 5.01, 6.73). Thus, Figure 3 in this cohort, the prolate ellipsoid formula underestimated planimetric volume by 17% on average (95% confidence interval: 14%, 19%). Only 13% (eight of 60) of volumes recorded by using the prolate ellipsoid formula were within 10% of the reference planimetric volume. There was a significant difference between the measurement methods as assessed by using the paired Student t test (P.0001). When comparing the data for correlation, r 0.969, r (Fig 3a). The sample concordance correlation coefficient is in this cohort. The Bland-Altman plot demonstrates the discrepancy between the measurement techniques with a mean difference (bias) of 5.9 and a 95% confidence limit of agreement of 12.4 to 0.6 (Fig 3b). Our subjective assessment of threedimensional rendered data showed that the prostate shape demonstrated variation as the volume increased secondary to asymmetric lobar enlargement (Fig 1b). Below 55 cm 3, prostate glands tended to have a consistent shape. Above 55 cm 3, there was more variation in shape and less predictability in calculated volume. The mathematic best-fit volume formula for prostate glands smaller than 55 cm 3 is composed of onehalf of a prolate ellipsoid and onehalf of an elliptical cylinder (Fig 2b). This shape resembles a bullet, with the flat part corresponding to the base and the rounded end corresponding to the apex. For such a bullet shape, the volume formula computes as: length height width ( /4.8), or length height width When the bullet formula is applied to the same cohort of 60 patients, the mean prostate volume is cm (range, cm 3 ). The mean difference in volume measurement between the new bullet formula and planimetry is reduced to 1.46 cm 3 (95% confidence interval: 0.39, 2.53). Seventyfive percent (45 of 60) of volumes calculated by using the bullet formula are now within 10% of the planimetric volume. However, there is still a significant difference between the volumes obtained with the two methods by using the paired t test (P.008). When we analyzed only the prostate glands smaller than 55 cm 3 (55 of 60), there was no significant difference between the groups as assessed by using the paired t test (P.14). The Pearson correlation coefficient did not change significantly when compared with the prolate ellipsoid formula (r 0.967, r ) (Fig 4). However, the Lin concordance correlation coefficient increased from 0.87 to 0.95 when switching to the bullet formula. We subsequently applied the bullet Figure 3: (a) Scatterplot of volume data compares conventional prolate ellipsoid volume calculations with reference standard volume at planimetry. Identity line represents perfect agreement for data. (b) Bland-Altman diagram of same data set. Data should plot close to identity line if good agreement is seen between techniques. 276 Radiology: Volume 250: Number 1 January 2009

5 Figure 4 Figure 4: (a) Scatterplot with linear fit compares bullet formula to planimetry for all 60 patients initially evaluated. (b) Bland-Altman diagram of a. (c) Scatterplot of prostate glands measuring less than 55 cm 3 by using bullet formula. (d) Bland-Altman diagram of c. formula to the next 78 patients referred for brachytherapy. In this group, the Lin concordance correlation coefficient increased from 0.83 to Data plotted closer to the identity line (45 ) when the bullet formula was used (Fig 5). By using the prolate ellipsoid formula in this cohort, 17% (13 of 78) were within 10% of the planimetric volume. However, by using the bullet formula, 67% (52 of 78) were within 10% of the planimetric volume (Table). Interobserver measurement accuracy of prostate dimensions from planimetric data are demonstrated in the scatterplot in Figure 6. The concordance correlation coefficient for two independent observers is high at Discussion Currently, prostate volume is calculated at the time of outpatient prostate transrectal US-guided biopsy. While the accuracy of volume calculations by using a three-dimensional measurement method (length height width) will always be limited when compared with a planimetry-based method, it is a measurement that is used to clinically assess a patient s suitability for prostate cancer treatment; thus, its accuracy is important. There are a number of factors that have to be taken into account when assessing the capability of a method to help estimate actual prostate gland size. The re- Radiology: Volume 250: Number 1 January

6 Figure 5 producibility of measurements is clearly important and an essential factor in the use of the prolate ellipsoid formula (9). Prostate gland dimensions, determined by using nonplanimetric transrectal US, is the principal source of error that contributes to decreased precision. It can be minimized by employing a strict measurement technique; in particular, ensuring that the height of the gland is always measured in the sagittal plane orthogonal to the length measurement, reducing any so-called salami effect (10). This effect predominately occurs when the prostate height is measured from the axial view. The prostate section that is defined by the probe depends on the operator s angle relative to the long axis, which is extremely difficult to judge on an axial view alone. We have demonstrated that the prolate ellipsoid formula is not accurate at predicting prostate volume even when using measurements obtained from planimetric US images that were all performed by a single experienced operator in identical conditions (patient in lithotomy position receiving general anesthetic). To our knowledge, this is the first study to employ rigorous statistical techniques and methods to minimize confounding factors in prostate volume measurement. There are a number of published studies recommending the prolate ellipsoid method as a useful alternative to planimetry in outpatient transrectal US prostate volume measurement (3,11, 12). In particular, Littrup et al (3) used a similar biplanar probe for their threedimensional measurements in a cohort of patients with prostate volumes ranging from 20 to 100 cm 3. These previous studies demonstrated good Pearson correlation of transrectal US volumes with planimetry or radical prostatectomy volumes. However, the Pearson correlation coefficient only demonstrates whether a linear association exists between two variables. There will inevitably be good linear association between tests that measure the same variable, but this does not mean that there is good agreement between two measurements. In our study, we used two additional statistical tests. The Bland-Altman plot is specifically used to assess the agreement between two methods of clinical measurement. The concordance correlation coefficient published by Lin (8) has been shown to be a robust method at establishing the strength of agreement between two measurements. In contrast to the Pearson correlation coefficient, it contains a measure of how far a best-fit line deviates from the identity line through the origin. In this respect, it is superior to the Pearson correlation coefficient in this type of study. Of note, prostatectomy specimens are not a standard of reference in a study of prostate volume, as there is considerable prostate tissue shrinkage ex vivo (10,13). While the volume calculated at stepping planimetry is prone to some error owing to the use of 5-mm acquisition increments, it is regarded as an accurate method of measuring in vivo volumes (14). The use of reconstructed multiplanar images obtained at the time of planimetry allows for an accurate method of deriving dimensional measurement free from temporal- and technique-derived confounding factors. In our study, we calculated the transrectal US volumes from the height, length, and width measurements obtained at planimetry. To eliminate possible confounding variables, such as interobserver variation and volume change between outpatient transrectal US and brachytherapy treatment, the outpatient transrectal US volumes (obtained by numerous observers with different US equipment) were not used. In addition, any potential for discrepancy in prostate dimension measurement owing to patient positioning is eliminated in this study by comparing volumes while the patient remains in one position (in this case, dorsolithotomy). Our study demonstrates that the prolate ellipsoid formula underesti- Figure 5: Scatterplots of second patient cohort (n 78) referred for brachytherapy show (a) conventional prolate ellipsoid formula compared with planimetry and (b) bullet formula compared with planimetry. 278 Radiology: Volume 250: Number 1 January 2009

7 Overview of Statistical Results Prostate Parameter Mean Difference SD (ml) P Value* r Value Lin Concordance First 60 patients Prostate 55 cm 3 Prolate ellipsoid vs planimetry Bullet shape vs planimetry Prostate 55 cm 3 Prolate ellipsoid vs planimetry Bullet shape vs planimetry Next 78 patients Prostate 55 cm 3 Prolate ellipsoid vs planimetry Bullet shape vs planimetry Prostate 55 cm 3 Prolate ellipsoid vs planimetry Bullet shape vs planimetry Note. SD Standard deviation. * Calculated by using Student t test. Figure 6 Figure 6: Scatterplot of bullet volume calculations from two independent observers. Plotting of measurements close to identity line shows low interobserver error. mates the planimetric prostate volume by 17%, supporting the results of Nathan et al (15), who showed that planimetric volumes were 17% greater than those of outpatient transrectal US measurements. By examining the rendered prostate shape, we observed that the prolate ellipsoid shape underestimates the size of the prostate gland and thus intrinsically underestimates the prostate volume by using the measurements obtained. Our bullet formula compensates for this inaccuracy. Its application to the same prostate dimensions significantly improved the ability of a formulaic method to more accurately predict planimetric volume. This is demonstrated with improved Bland- Altman plots (Figs 5 and 6) and, in particular, improved Lin concordance correlation coefficient from 0.87 to We have validated the bullet formula by confirming its accuracy when compared with planimetry in the second set of 78 patients referred for brachytherapy. Overall, between 66% and 75% of prostate volumes are estimated within 10% of the planimetric volume by using the bullet formula, as opposed to between 13% and 17% by using the prolate ellipsoid method. More importantly, for glands that were less than 55 cm 3 in volume, the bullet formula is highly accurate. This is relevant for patients considering brachytherapy, since 50 cm 3 is the approximate cutoff volume of suitability for this form of treatment. Whereas the prostate volume is more than cm 3, patients are usually deemed unsuitable for brachytherapy, meaning that inaccuracy in precise measurement above this volume is not clinically important. We recognize that the measurements used to calculate volume in this study with the patient lying in the lithotomy position are likely to be more accurate than measurements obtained at outpatient transrectal US when the patient is lying in a lateral position. Nonetheless, the bullet formula significantly improved agreement with the reference standard planimetric volume, as calculated by using the stepping method. Thus, it can be inferred that the bullet formula should also improve the accuracy of the outpatient transrectal US measurement. We also recognize that a single operator, experienced in prostate brachytherapy, is likely to make more accurate measurements than a radiologist who performs occasional outpatient transrectal US. Nonetheless, if the bullet formula significantly improved accuracy when the measurements were obtained by an experienced operator, it should do the same for the less-experienced radiologist. This study demonstrated an inherent error in the prolate ellipsoid technique by underestimating the size of the base of the prostate gland. Any volume Radiology: Volume 250: Number 1 January

8 calculation made on the basis of three measurements can only estimate actual size. However, if the calculation is important, it must be as accurate as possible. We have demonstrated that a significant improvement in prostate volume calculations is possible by using a volume formula computed to better represent the majority of prostate shapes in men suitable for prostate brachytherapy. We suggest that the current volume calculation: length height width ( / 6) (or, length height width 0.52) be replaced by the bullet formula: length height width ( /4.8) (or, length height width 0.65), especially in prostate glands of less than 55 cm 3 in volume. References 1. Langley SE, Laing R. Prostate brachytherapy has come of age: a review of the technique and results. BJU Int 2002;89(3): Radwan MH, Yan Y, Luly JR, et al. Prostatespecific antigen density predicts adverse pathology and increased risk of biochemical failure. Urology 2007;69(6): Littrup PJ, Williams CR, Egglin TK, Kane RA. Determination of prostate volume with transrectal US for cancer screening. II. Accuracy of in vitro and in vivo techniques. Radiology 1991;179(1): Al-Qaisieh B, Brearley E, St Clair S, Flynn A. A study of a pretreatment method to predict the number of I-125 seeds required for prostate brachytherapy. Int J Radiat Oncol Biol Phys 2006;65(1): Armpilia CI, Dale RG, Coles IP, Jones B, Antipas V. The determination of radiobiologically optimized half-lives for radionuclides used in permanent brachytherapy implants. Int J Radiat Oncol Biol Phys 2003;55(2): Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1(8476): Hilson A. Bland-Altman plot [letter]. Radiology 2004;231(2): Lin LI. A concordance correlation coefficient to evaluate reproducibility. Biometrics 1989; 45(1): Bazinet M, Karakiewicz PI, Aprikian AG, et al. Reassessment of nonplanimetric transrectal ultrasound prostate volume estimates. Urology 1996;47(6): Dähnert WF. Determination of prostate volume with transrectal US for cancer screening [letter]. Radiology 1992;183(3): Terris MK, Stamey TA. Determination of prostate volume by transrectal ultrasound. J Urol 1991;145(5): Kimura A, Kurooka Y, Hirasawa K, Kitamura T, Kawabe K. Accuracy of prostatic volume calculation in transrectal ultrasonography. Int J Urol 1995;2(4): Jonmarker S, Valdman A, Lindberg A, Hellström M, Egevad L. Tissue shrinkage after fixation with formalin injection of prostatectomy specimens. Virchows Arch 2006;449(3): Miyashita H, Watanabe H, Ohe H, Saitoh M, Oogama Y, Iijima S. Transrectal ultrasonotomography of the canine prostate. Prostate 1984;5(4): Nathan MS, Seenivasagam K, Mei Q, Wickham JE, Miller RA. Transrectal ultrasonography: why are estimates of prostate volume and dimension so inaccurate? Br J Urol 1996;77(3): Radiology: Volume 250: Number 1 January 2009

Comparison Of Accuracy Of Prostate Model Volume Measurement Between 2 Dimensional And 3 Dimensional Ultrasonography.

Comparison Of Accuracy Of Prostate Model Volume Measurement Between 2 Dimensional And 3 Dimensional Ultrasonography. ISPUB.COM The Internet Journal of Radiology Volume 14 Number 2 Comparison Of Accuracy Of Prostate Model Volume Measurement Between 2 Dimensional And 3 Dimensional Ultrasonography. S Park, S Hwang Citation

More information

@Original Contribution

@Original Contribution Pergamon Ultrasound in Med. & Biol., Vol. 21, No. 1, pp. 11-16, 1995 Copyright 0 1995 Elsevier Science Ltd P&ted in the USA. All rights reserved 0301.5629/95 $9.50 + 00 0301-5629(94)00084-O @Original Contribution

More information

Prostate weight is the preferred measure of prostate size in radical prostatectomy cohorts

Prostate weight is the preferred measure of prostate size in radical prostatectomy cohorts Prostate weight is the preferred measure of prostate size in radical prostatectomy cohorts Matthew K.H. Hong, Henry H.I. Yao, Kathryn Rzetelski-West, Benjamin Namdarian, John Pedersen *, Justin S. Peters,

More information

TRANSRECTAL ULTRASOUND-GUIDED PROSTATE BRACHYTHERAPY

TRANSRECTAL ULTRASOUND-GUIDED PROSTATE BRACHYTHERAPY TRANSRECTAL ULTRASOUND-GUIDED PROSTATE BRACHYTHERAPY 1 TRANSRECTAL ULTRASOUND-GUIDED PROSTATE BRACHYTHERAPY BRENDAN CAREY, MD TRANSRECTAL ULTRASOUND-GUIDED PROSTATE BRACHYTHERAPY 2 TRANSRECTAL ULTRASOUND-GUIDED

More information

INTEROBSERVER VARIATION OF PROSTATIC VOLUME ESTIMATION WITH DIGITAL RECTAL EXAMINATION BY UROLOGICAL STAFFS WITH DIFFERENT EXPERIENCES

INTEROBSERVER VARIATION OF PROSTATIC VOLUME ESTIMATION WITH DIGITAL RECTAL EXAMINATION BY UROLOGICAL STAFFS WITH DIFFERENT EXPERIENCES Clinical Urology International Braz J Urol Official Journal of the Brazilian Society of Urology DIGITAL RECTAL EXAMINATION BY UROLOGICAL STAFFS Vol. 30 (6): 466-471, November - December, 2004 INTEROBSERVER

More information

Poor reproducibility of PIRADS score in two multiparametric MRIs before biopsy in men with elevated PSA

Poor reproducibility of PIRADS score in two multiparametric MRIs before biopsy in men with elevated PSA https://doi.org/10.1007/s00345-018-2252-4 TOPIC PAPER Poor reproducibility of PIRADS score in two multiparametric MRIs before biopsy in men with elevated PSA Stig Müller 1,2 Gunder Lilleaasen 1 Tor Erik

More information

MEDICAL POLICY. SUBJECT: BRACHYTHERAPY OR RADIOACTIVE SEED IMPLANTATION FOR PROSTATE CANCER POLICY NUMBER: CATEGORY: Technology Assessment

MEDICAL POLICY. SUBJECT: BRACHYTHERAPY OR RADIOACTIVE SEED IMPLANTATION FOR PROSTATE CANCER POLICY NUMBER: CATEGORY: Technology Assessment MEDICAL POLICY SUBJECT: BRACHYTHERAPY OR PAGE: 1 OF: 5 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy

More information

The reliability of ultrasonographic measurements for testicular volume assessment: comparison of three common formulas with true testicular volume

The reliability of ultrasonographic measurements for testicular volume assessment: comparison of three common formulas with true testicular volume Original Article Asian Journal of Andrology (2009): 261 265 2009 AJA, SIMM & SJTU All rights reserved 1008-682X/09 $ 30.00 www.nature.com/aja 261 The reliability of ultrasonographic measurements for testicular

More information

Are extended biopsies really necessary to improve prostate cancer detection?

Are extended biopsies really necessary to improve prostate cancer detection? (2003) 6, 250 255 & 2003 Nature Publishing Group All rights reserved 1365-7852/03 $25.00 www.nature.com/pcan Are extended biopsies really necessary to improve prostate cancer detection? R Damiano*,1, R

More information

Advances in Treatment of Cancer by Brachytherapy in Kenya, in Particular, Prostate Cancer

Advances in Treatment of Cancer by Brachytherapy in Kenya, in Particular, Prostate Cancer Research Article imedpub Journals www.imedpub.com Journal Of Medical Physics And Applied Sciences ISSN 2574-285X DOI: 1.21767/2574-285X.12 Advances in Treatment of Cancer by Brachytherapy in Kenya, in

More information

MEDICAL POLICY SUBJECT: TRANSRECTAL ULTRASOUND (TRUS)

MEDICAL POLICY SUBJECT: TRANSRECTAL ULTRASOUND (TRUS) MEDICAL POLICY SUBJECT: TRANSRECTAL ULTRASOUND 06/16/05, 05/18/06, 03/15/07, 02/21/08 PAGE: 1 OF: 5 If the member's subscriber contract excludes coverage for a specific service it is not covered under

More information

Trina Lynd, M.S. Medical Physicist Lifefirst Imaging & Oncology Cullman, AL Tri-State Alabama, Louisiana and Mississippi Spring 2016 Meeting April

Trina Lynd, M.S. Medical Physicist Lifefirst Imaging & Oncology Cullman, AL Tri-State Alabama, Louisiana and Mississippi Spring 2016 Meeting April Trina Lynd, M.S. Medical Physicist Lifefirst Imaging & Oncology Cullman, AL Tri-State Alabama, Louisiana and Mississippi Spring 2016 Meeting April 17, 2016 Discuss permanent prostate brachytherapy and

More information

Research Article Comparison of Colour Duplex Ultrasound with Computed Tomography to Measure the Maximum Abdominal Aortic Aneurysmal Diameter

Research Article Comparison of Colour Duplex Ultrasound with Computed Tomography to Measure the Maximum Abdominal Aortic Aneurysmal Diameter International Vascular Medicine, Article ID 574762, 4 pages http://dx.doi.org/10.1155/2014/574762 Research Article Comparison of Colour Duplex Ultrasound with Computed Tomography to Measure the Maximum

More information

Preoperative Gleason score, percent of positive prostate biopsies and PSA in predicting biochemical recurrence after radical prostatectomy

Preoperative Gleason score, percent of positive prostate biopsies and PSA in predicting biochemical recurrence after radical prostatectomy JBUON 2013; 18(4): 954-960 ISSN: 1107-0625, online ISSN: 2241-6293 www.jbuon.com E-mail: editorial_office@jbuon.com ORIGINAL ARTICLE Gleason score, percent of positive prostate and PSA in predicting biochemical

More information

Radiation Therapy for Prostate Cancer. Resident Dept of Urology General Surgery Grand Round November 24, 2008

Radiation Therapy for Prostate Cancer. Resident Dept of Urology General Surgery Grand Round November 24, 2008 Radiation Therapy for Prostate Cancer Amy Hou,, MD Resident Dept of Urology General Surgery Grand Round November 24, 2008 External Beam Radiation Advances Improving Therapy Generation of linear accelerators

More information

MEDICAL POLICY SUBJECT: BRACHYTHERAPY OR RADIOACTIVE SEED IMPLANTATION FOR PROSTATE CANCER

MEDICAL POLICY SUBJECT: BRACHYTHERAPY OR RADIOACTIVE SEED IMPLANTATION FOR PROSTATE CANCER MEDICAL POLICY SUBJECT: BRACHYTHERAPY OR PAGE: 1 OF: 6 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy

More information

Quality Assurance of Ultrasound Imaging in Radiation Therapy. Zuofeng Li, D.Sc. Murty S. Goddu, Ph.D. Washington University St.

Quality Assurance of Ultrasound Imaging in Radiation Therapy. Zuofeng Li, D.Sc. Murty S. Goddu, Ph.D. Washington University St. Quality Assurance of Ultrasound Imaging in Radiation Therapy Zuofeng Li, D.Sc. Murty S. Goddu, Ph.D. Washington University St. Louis, Missouri Typical Applications of Ultrasound Imaging in Radiation Therapy

More information

Does Abstinence From Ejaculation Before Prostate MRI Improve Evaluation of the Seminal Vesicles?

Does Abstinence From Ejaculation Before Prostate MRI Improve Evaluation of the Seminal Vesicles? Genitourinary Imaging Original Research Kabakus et al. Abstinence From Ejaculation Before Prostate MRI Genitourinary Imaging Original Research Ismail M. Kabakus 1 Samuel Borofsky 2 Francesca V. Mertan

More information

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 4,100 116,000 120M Open access books available International authors and editors Downloads Our

More information

Effect of intravenous contrast medium administration on prostate diffusion-weighted imaging

Effect of intravenous contrast medium administration on prostate diffusion-weighted imaging Effect of intravenous contrast medium administration on prostate diffusion-weighted imaging Poster No.: C-1766 Congress: ECR 2015 Type: Authors: Keywords: DOI: Scientific Exhibit J. Bae, C. K. Kim, S.

More information

MR-US Fusion Guided Biopsy: Is it fulfilling expectations?

MR-US Fusion Guided Biopsy: Is it fulfilling expectations? MR-US Fusion Guided Biopsy: Is it fulfilling expectations? Kenneth L. Gage MD, PhD Assistant Member Department of Diagnostic Imaging and Interventional Radiology 4 th Annual New Frontiers in Urologic Oncology

More information

Saturation Biopsy for Diagnosis and Staging and Management of Prostate Cancer

Saturation Biopsy for Diagnosis and Staging and Management of Prostate Cancer Saturation Biopsy for Diagnosis and Staging and Management of Prostate Cancer Policy Number: 7.01.121 Last Review: 2/2018 Origination: 8/2006 Next Review: 8/2018 Policy Blue Cross and Blue Shield of Kansas

More information

AN APPROACH FOR ASSESSMENT OF TUMOR VOLUME FROM MAMMOGRAPHY IN LOCALLY ADVANCED BREAST CANCER. Gupreet Singh

AN APPROACH FOR ASSESSMENT OF TUMOR VOLUME FROM MAMMOGRAPHY IN LOCALLY ADVANCED BREAST CANCER. Gupreet Singh Malaysian Journal of Medical Sciences, Vol. 15, No. 1, January 2008 (37-41) ORIGINAL ARTICLE AN APPROACH FOR ASSESSMENT OF TUMOR VOLUME FROM MAMMOGRAPHY IN LOCALLY ADVANCED BREAST CANCER Gupreet Singh

More information

VALIDATION OF CONTINUOUS GLUCOSE MONITORING IN CHILDREN AND ADOLESCENTS WITH CYSTIC FIBROSIS - A PROSPECTIVE COHORT STUDY

VALIDATION OF CONTINUOUS GLUCOSE MONITORING IN CHILDREN AND ADOLESCENTS WITH CYSTIC FIBROSIS - A PROSPECTIVE COHORT STUDY Diabetes Care Publish Ahead of Print, published online March 11, 2009 Validation of CGM in Children with CF VALIDATION OF CONTINUOUS GLUCOSE MONITORING IN CHILDREN AND ADOLESCENTS WITH CYSTIC FIBROSIS

More information

THE UROLOGY GROUP

THE UROLOGY GROUP THE UROLOGY GROUP www.urologygroupvirginia.com 1860 Town Center Drive Suite 150/160 Reston, VA 20190 703-480-0220 19415 Deerfield Avenue Suite 112 Leesburg, VA 20176 703-724-1195 224-D Cornwall Street,

More information

ADVICE TO PATIENTS REQUESTING PSA MEASUREMENT

ADVICE TO PATIENTS REQUESTING PSA MEASUREMENT Frequently-Asked Questions What is the aim of this leaflet? Prostate cancer is a serious condition. The PSA test, which can give an early indication of prostate cancer, is available to you if you want

More information

BLADDER PROSTATE PENIS TESTICLES BE YO ND YO UR CA NC ER

BLADDER PROSTATE PENIS TESTICLES BE YO ND YO UR CA NC ER BLADDER PROSTATE PENIS TESTICLES THE PROSTATE IS A SMALL, WALNUT-SIZED GLAND THAT IS PART OF THE MALE REPRODUCTIVE SYSTEM. IT RESTS BELOW THE BLADDER, IN FRONT OF THE RECTUM AND SURROUNDS PART OF THE URETHRA.

More information

Saturation Biopsy for Diagnosis and Staging and Management of Prostate Cancer

Saturation Biopsy for Diagnosis and Staging and Management of Prostate Cancer Saturation Biopsy for Diagnosis and Staging and Management of Prostate Cancer Policy Number: 7.01.121 Last Review: 2/2019 Origination: 8/2006 Next Review: 8/2019 Policy Blue Cross and Blue Shield of Kansas

More information

Comparison of contemporary methods for estimating prostate tumour volume in pathological specimens

Comparison of contemporary methods for estimating prostate tumour volume in pathological specimens Comparison of contemporary methods for estimating prostate tumour volume in pathological specimens Marlon Perera, Nathan Lawrentschuk*, Damien Bolton* and David Clouston Western Health, *Department of

More information

Cancer. Description. Section: Surgery Effective Date: October 15, 2016 Subsection: Original Policy Date: September 9, 2011 Subject:

Cancer. Description. Section: Surgery Effective Date: October 15, 2016 Subsection: Original Policy Date: September 9, 2011 Subject: Subject: Saturation Biopsy for Diagnosis, Last Review Status/Date: September 2016 Page: 1 of 9 Saturation Biopsy for Diagnosis, Description Saturation biopsy of the prostate, in which more cores are obtained

More information

Contribution of prostate-specific antigen density in the prediction of prostate cancer: Does prostate volume matter?

Contribution of prostate-specific antigen density in the prediction of prostate cancer: Does prostate volume matter? ORIGINAL ARTICLE Gulhane Med J 2018;60: 14-18 Gülhane Faculty of Medicine 2018 doi: 10.26657/gulhane.00010 Contribution of prostate-specific antigen density in the prediction of prostate cancer: Does prostate

More information

prostate cancer diagnosis and patient management

prostate cancer diagnosis and patient management Isabelle oulay-oletta, M Groupe hospitalier Paris Saint-Joseph (St. Joseph Hospital) in Paris, France Synthetic diffusion: a robust sequence for prostate cancer diagnosis and patient management Located

More information

Varian Acuity BrachyTherapy Suite One Room Integrated Image-Guided Brachytherapy

Varian Acuity BrachyTherapy Suite One Room Integrated Image-Guided Brachytherapy Varian Acuity BrachyTherapy Suite One Room Integrated Image-Guided Brachytherapy The Acuity BrachyTherapy Suite Integrating Imaging, Planning, and Treatment in a Single Room Each component draws on the

More information

DETERMINATION OF NORMAL RANGE OF ULTRASONIC SIZES OF PROSTATE IN OUR LOCAL ENVIRONMENT

DETERMINATION OF NORMAL RANGE OF ULTRASONIC SIZES OF PROSTATE IN OUR LOCAL ENVIRONMENT DETERMINATION OF NORMAL RANGE OF ULTRASONIC SIZES OF PROSTATE IN OUR LOCAL ENVIRONMENT Marchie T.T, MBBS, FWACS, FICS, Diagnostic Urology Unit, Department Of Radiology, University Of Benin Teaching Hospital,

More information

Using Gray-Scale and Color and Power Doppler Sonography to Detect Prostatic Cancer

Using Gray-Scale and Color and Power Doppler Sonography to Detect Prostatic Cancer Using Gray-Scale and Color and Power Doppler Sonography to Detect Prostatic Cancer Ethan J. Halpern 1 Stephen E. Strup 2 OBJECTIVE. We performed a prospective study to assess gray-scale and color and power

More information

Extended 12-Core Prostate Biopsy Increases Both the Detection of Prostate Cancer and the Accuracy of Gleason Score

Extended 12-Core Prostate Biopsy Increases Both the Detection of Prostate Cancer and the Accuracy of Gleason Score european urology xxx (2005) xxx xxx available at www.sciencedirect.com journal homepage: www.europeanurology.com Prostate Cancer Extended 12-Core Prostate Biopsy Increases Both the Detection of Prostate

More information

Since the beginning of the prostate-specific antigen (PSA) era in the. Characteristics of Insignificant Clinical T1c Prostate Tumors

Since the beginning of the prostate-specific antigen (PSA) era in the. Characteristics of Insignificant Clinical T1c Prostate Tumors 2001 Characteristics of Insignificant Clinical T1c Prostate Tumors A Contemporary Analysis Patrick J. Bastian, M.D. 1 Leslie A. Mangold, B.A., M.S. 1 Jonathan I. Epstein, M.D. 2 Alan W. Partin, M.D., Ph.D.

More information

PCa Commentary. Executive Summary: The "PCa risk increased directly with increasing phi values."

PCa Commentary. Executive Summary: The PCa risk increased directly with increasing phi values. 1101 Madison Street Suite 1101 Seattle, WA 98104 P 206-215-2490 www.seattleprostate.com PCa Commentary Volume 77 September October 2012 CONTENT Page The Prostate 1 Health Index Active Surveillance 2 A

More information

THE SIGNIFICANCE OF HYPOECHOIC LESION DIRECTED AND TRANSITION ZONE BIOPSIES IN IMPROVING THE DIAGNOSTIC ABILITY IN PROSTATE CANCER

THE SIGNIFICANCE OF HYPOECHOIC LESION DIRECTED AND TRANSITION ZONE BIOPSIES IN IMPROVING THE DIAGNOSTIC ABILITY IN PROSTATE CANCER Clinical Urology Brazilian Journal of Urology Official Journal of the Brazilian Society of Urology Vol. 27 (3): 222-226, May - June, 2001 THE SIGNIFICANCE OF HYPOECHOIC LESION DIRECTED AND TRANSITION ZONE

More information

Prediction of Postoperative Tumor Size in Breast Cancer Patients by Clinical Assessment, Mammography and Ultrasonography

Prediction of Postoperative Tumor Size in Breast Cancer Patients by Clinical Assessment, Mammography and Ultrasonography Prediction of Postoperative Tumor Size in Breast Cancer Patients by Clinical Assessment, Mammography and Ultrasonography Eyad Fawzi AlSaeed 1 and Mutahir A. Tunio 2* 1 Consultant Radiation Oncology, Chairman

More information

Clinical Commissioning Policy Proposition: Proton Beam Therapy for Cancer of the Prostate

Clinical Commissioning Policy Proposition: Proton Beam Therapy for Cancer of the Prostate Clinical Commissioning Policy Proposition: Proton Beam Therapy for Cancer of the Prostate Reference: NHS England B01X09 First published: March 2016 Prepared by NHS England Specialised Services Clinical

More information

Real-time Elastography for the Diagnosis of Prostate Cancer: Evaluation of Elastographic Moving Images

Real-time Elastography for the Diagnosis of Prostate Cancer: Evaluation of Elastographic Moving Images Real-time Elastography for the Diagnosis of Prostate Cancer: Evaluation of Elastographic Moving Images Tomoaki Miyagawa 1, Masakazu Tsutsumi 2, Takeshi Matsumura 3, Natsui Kawazoe 2, Satoru Ishikawa 2,

More information

Central European Journal of Urology

Central European Journal of Urology 270 Central European Journal of Urology O R I G I N A L P A P E R urological oncology Low-dose-rate brachytherapy as a minimally invasive curative treatment for localised prostate cancer has excellent

More information

Correlation of Gleason Scores Between Needle-Core Biopsy and Radical Prostatectomy Specimens in Patients with Prostate Cancer

Correlation of Gleason Scores Between Needle-Core Biopsy and Radical Prostatectomy Specimens in Patients with Prostate Cancer ORIGINAL ARTICLE Correlation of Gleason Scores Between Needle-Core Biopsy and Radical Prostatectomy Specimens in Patients with Prostate Cancer Teng-Fu Hsieh, Chao-Hsian Chang, Wen-Chi Chen, Chien-Lung

More information

DOSIMETRIC OPTIONS AND POSSIBILITIES OF PROSTATE LDR BRACHYTHERAPY WITH PERMANENT I-125 IMPLANTS

DOSIMETRIC OPTIONS AND POSSIBILITIES OF PROSTATE LDR BRACHYTHERAPY WITH PERMANENT I-125 IMPLANTS DOSIMETRIC OPTIONS AND POSSIBILITIES OF PROSTATE LDR BRACHYTHERAPY WITH PERMANENT I-125 IMPLANTS Andrius IVANAUSKAS*, Eduardas ALEKNAVIČIUS*, Arvydas BURNECKIS*, Albert MILLER *Institute of Oncology Vilnius

More information

The introduction of serum prostate-specific antigen

The introduction of serum prostate-specific antigen ADULT UROLOGY CME ARTICLE COMPARING PSA OUTCOME AFTER RADICAL PROSTATECTOMY OR MAGNETIC RESONANCE IMAGING- GUIDED PARTIAL PROSTATIC IRRADIATION IN SELECT PATIENTS WITH CLINICALLY LOCALIZED ADENOCARCINOMA

More information

Prostate MRI Hamidreza Abdi, MD,FEBU Post Doctoral Fellow Vancouver Prostate Centre UBC Department of Urologic Sciences May-20144

Prostate MRI Hamidreza Abdi, MD,FEBU Post Doctoral Fellow Vancouver Prostate Centre UBC Department of Urologic Sciences May-20144 Prostate MRI Hamidreza Abdi, MD,FEBU Post Doctoral Fellow Vancouver Prostate Centre UBC Department of Urologic Sciences May-20144 Objectives: Detection of prostate cancer the need for better imaging What

More information

Subject Index. Androgen antiandrogen therapy, see Hormone ablation therapy, prostate cancer synthesis and metabolism 49

Subject Index. Androgen antiandrogen therapy, see Hormone ablation therapy, prostate cancer synthesis and metabolism 49 OOOOOOOOOOOOOOOOOOOOOOOOOOOOOO Subject Index Androgen antiandrogen therapy, see Hormone ablation therapy, synthesis and metabolism 49 Bacillus Calmette-Guérin adjunct therapy with transurethral resection

More information

Transperineal Interstitial Permanent Prostate Brachytherapy (TIPPB) Quality Assurance Guidelines

Transperineal Interstitial Permanent Prostate Brachytherapy (TIPPB) Quality Assurance Guidelines Prostate Brachytherapy QA Page 1 of 1 Transperineal Interstitial Permanent Prostate Brachytherapy (TIPPB) Quality Assurance Guidelines I. Purpose Table of Contents II. III. IV. Background Credentialing

More information

20 Prostate Cancer Dan Ash

20 Prostate Cancer Dan Ash 20 Prostate Cancer Dan Ash 1 Introduction Prostate cancer is a disease of ageing men for which the aetiology remains unknown. The incidence rises up to 30 to 40% in men over 80. The symptoms of localised

More information

MRI-targeted, transrectal ultrasound-guided prostate biopsy for suspected prostate malignancy: A pictorial review

MRI-targeted, transrectal ultrasound-guided prostate biopsy for suspected prostate malignancy: A pictorial review MRI-targeted, transrectal ultrasound-guided prostate biopsy for suspected prostate malignancy: A pictorial review Poster No.: C-1208 Congress: ECR 2014 Type: Educational Exhibit Authors: J. Murphy, M.

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Saturation Biopsy for Diagnosis, Staging, and Management of Prostate File Name: Origination: Last CAP Review: Next CAP Review: Last Review: saturation_biopsy_for_diagnosis_ staging_and_management_of_prostate_cancer

More information

Over the last decade, prostate brachytherapy a radiation treatment

Over the last decade, prostate brachytherapy a radiation treatment 135 Modern Prostate Brachytherapy Prostate Specific Antigen Results in 219 Patients with up to 12 Years of Observed Follow-Up Haakon Ragde, M.D. 1 Leroy J. Korb, M.D. 1 Abdel-Aziz Elgamal, M.D. 2 Gordon

More information

The Impact of MRI-TRUS Cognitively Targeted Biopsy on the Incidence of Pathologic Upgrading After Radical Prostatectomy

The Impact of MRI-TRUS Cognitively Targeted Biopsy on the Incidence of Pathologic Upgrading After Radical Prostatectomy Original Article World J Nephrol Urol. 2018;7(1):12-16 The Impact of MRI-TRUS Cognitively Targeted Biopsy on the Incidence of Pathologic Upgrading After Radical Prostatectomy Ragheed Saoud a, Albert El-Haj

More information

Chapter 6. Hester Gietema Cornelia Schaefer-Prokop Willem Mali Gerard Groenewegen Mathias Prokop. Accepted for publication in Radiology

Chapter 6. Hester Gietema Cornelia Schaefer-Prokop Willem Mali Gerard Groenewegen Mathias Prokop. Accepted for publication in Radiology Chapter 6 Interscan variability of semiautomated volume measurements in intraparenchymal pulmonary nodules using multidetector-row computed tomography: Influence of inspirational level, nodule size and

More information

The benefit of a preplanning procedure - view from oncologist. Dorota Kazberuk November, 2014 Otwock

The benefit of a preplanning procedure - view from oncologist. Dorota Kazberuk November, 2014 Otwock The benefit of a preplanning procedure - view from oncologist Dorota Kazberuk 21-22 November, 2014 Otwock Brachytherapy is supreme tool in prostate cancer management with a wide range of options in every

More information

MRI in the Enhanced Detection of Prostate Cancer: What Urologists Need to Know

MRI in the Enhanced Detection of Prostate Cancer: What Urologists Need to Know MRI in the Enhanced Detection of Prostate Cancer: What Urologists Need to Know Michael S. Cookson, MD, FACS Professor and Chair Department of Urology Director of Prostate and Urologic Oncology University

More information

Ultrasound - Prostate

Ultrasound - Prostate Scan for mobile link. Ultrasound - Prostate Ultrasound of the prostate uses sound waves to produce pictures of a man s prostate gland and to help diagnose symptoms such as difficulty urinating or an elevated

More information

Saturation Biopsy for Diagnosis, Staging, and Management of Prostate Cancer

Saturation Biopsy for Diagnosis, Staging, and Management of Prostate Cancer Saturation Biopsy for Diagnosis, Staging, and Management of Prostate Cancer Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana,

More information

Prostate Cancer. What is prostate cancer?

Prostate Cancer. What is prostate cancer? Scan for mobile link. Prostate Cancer Prostate cancer is a tumor of the prostate gland, which is located in front of the rectum and below the bladder. Your doctor may perform a physical exam, prostate-specific

More information

Patient Information. Prostate Tissue Ablation. High Intensity Focused Ultrasound for

Patient Information. Prostate Tissue Ablation. High Intensity Focused Ultrasound for High Intensity Focused Ultrasound for Prostate Tissue Ablation Patient Information CAUTION: Federal law restricts this device to sell by or on the order of a physician CONTENT Introduction... 3 The prostate...

More information

PROSTATE MRI. Dr. Margaret Gallegos Radiologist Santa Fe Imaging

PROSTATE MRI. Dr. Margaret Gallegos Radiologist Santa Fe Imaging PROSTATE MRI Dr. Margaret Gallegos Radiologist Santa Fe Imaging Topics of today s talk How does prostate MRI work? Definition of multiparametric (mp) MRI Anatomy of prostate gland and MRI imaging Role

More information

CONTEMPORARY UPDATE OF PROSTATE CANCER STAGING NOMOGRAMS (PARTIN TABLES) FOR THE NEW MILLENNIUM

CONTEMPORARY UPDATE OF PROSTATE CANCER STAGING NOMOGRAMS (PARTIN TABLES) FOR THE NEW MILLENNIUM RAPID COMMUNICATION CME ARTICLE CONTEMPORARY UPDATE OF PROSTATE CANCER STAGING NOMOGRAMS (PARTIN TABLES) FOR THE NEW MILLENNIUM ALAN W. PARTIN, LESLIE A. MANGOLD, DANA M. LAMM, PATRICK C. WALSH, JONATHAN

More information

ADVICE TO PATIENTS REQUESTING PSA MEASUREMENT FREQUENTLY-ASKED QUESTIONS

ADVICE TO PATIENTS REQUESTING PSA MEASUREMENT FREQUENTLY-ASKED QUESTIONS The British Association of Urological Surgeons 35-43 Lincoln s Inn Fields London WC2A 3PE Phone: Fax: Website: E-mail: +44 (0)20 7869 6950 +44 (0)20 7404 5048 www.baus.org.uk admin@baus.org.uk ADVICE TO

More information

Prostate Cancer: Low Dose Rate (Seed) Brachytherapy. Information for patients, families and friends

Prostate Cancer: Low Dose Rate (Seed) Brachytherapy. Information for patients, families and friends Prostate Cancer: Low Dose Rate (Seed) Brachytherapy Information for patients, families and friends About this booklet This booklet is designed to give you information about low dose-rate (seed) brachytherapy

More information

Normal tissue doses from MV image-guided radiation therapy (IGRT) using orthogonal MV and MV-CBCT

Normal tissue doses from MV image-guided radiation therapy (IGRT) using orthogonal MV and MV-CBCT Received: 28 September 2017 Revised: 17 November 2017 Accepted: 28 December 2017 DOI: 10.1002/acm2.12276 RADIATION ONCOLOGY PHYSICS Normal tissue doses from MV image-guided radiation therapy (IGRT) using

More information

Modifi ed CT perfusion contrast injection protocols for improved CBF quantifi cation with lower temporal sampling

Modifi ed CT perfusion contrast injection protocols for improved CBF quantifi cation with lower temporal sampling Investigations and research Modifi ed CT perfusion contrast injection protocols for improved CBF quantifi cation with lower temporal sampling J. Wang Z. Ying V. Yao L. Ciancibello S. Premraj S. Pohlman

More information

Localized Prostate Cancer Have we finally got it right? Shingai Mutambirwa Professor & Chair-Division Urology DGMAH & SMU Pretoria SOUTH AFRICA

Localized Prostate Cancer Have we finally got it right? Shingai Mutambirwa Professor & Chair-Division Urology DGMAH & SMU Pretoria SOUTH AFRICA Localized Prostate Cancer Have we finally got it right? Shingai Mutambirwa Professor & Chair-Division Urology DGMAH & SMU Pretoria SOUTH AFRICA ESMO Cape Town 14 Feb 2018 Disclosures Advisory boards/lecturer/consultant-

More information

Computer simulated additional deep apical biopsy enhances cancer detection in palpably benign prostate gland

Computer simulated additional deep apical biopsy enhances cancer detection in palpably benign prostate gland Blackwell Publishing AsiaMelbourne, AustraliaIJUInternational Journal of Urology0919-81722006 Blackwell Publishing Asia Pty Ltd? 200613?12901295Original ArticleAdditional apical biopsy in prostatic gland

More information

BRACHYTHERAPY FOR PROSTATE CANCER. Dr Brandon Nguyen MBBS(Hons), FRANZCR Radiation Oncologist, The Canberra Hospital

BRACHYTHERAPY FOR PROSTATE CANCER. Dr Brandon Nguyen MBBS(Hons), FRANZCR Radiation Oncologist, The Canberra Hospital BRACHYTHERAPY FOR PROSTATE CANCER Dr Brandon Nguyen MBBS(Hons), FRANZCR Radiation Oncologist, The Canberra Hospital PROSTATE BRACHYTHERAPY Why brachytherapy? How do we do it? What are the results? Questions?

More information

NATURAL EVOLUTION OF THE AORTA

NATURAL EVOLUTION OF THE AORTA UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA FACULTY OF GENERAL MEDICINE NATURAL EVOLUTION OF THE AORTA PhD THESIS ABSTRACT Scientific supervisor: Prof. Univ. Dr. Iancu Emil PLEȘEA PhD student: Oana

More information

A Phantom Study Comparing Ultrasound-Guided Liver Tumor Puncture Using New Real-Time 3D Ultrasound and Conventional 2D Ultrasound

A Phantom Study Comparing Ultrasound-Guided Liver Tumor Puncture Using New Real-Time 3D Ultrasound and Conventional 2D Ultrasound Gastrointestinal Imaging Original Research Sugimoto et al. 4D Ultrasound Guided Puncture for Focal Hepatic Lesions Gastrointestinal Imaging Original Research Katsutoshi Sugimoto 1 Fuminori Moriyasu 1 Junji

More information

Introduction. Key Words: high-grade prostatic intraepithelial neoplasia, HGPIN, radical prostatectomy, prostate biopsy, insignificant prostate cancer

Introduction. Key Words: high-grade prostatic intraepithelial neoplasia, HGPIN, radical prostatectomy, prostate biopsy, insignificant prostate cancer Prostate cancer after initial high-grade prostatic intraepithelial neoplasia and benign prostate biopsy Premal Patel, MD, 1 Jasmir G. Nayak, MD, 1,2 Zlatica Biljetina, MD, 4 Bryan Donnelly, MD 3, Kiril

More information

Interim Report. Prostate Cancer Fight Foundation Motorcycle Ride for Dad. February 7, Supporting Kingston s university hospitals:

Interim Report. Prostate Cancer Fight Foundation Motorcycle Ride for Dad. February 7, Supporting Kingston s university hospitals: Interim Report Prostate Cancer Fight Foundation Motorcycle Ride for Dad February 7, 2014 Supporting Kingston s university hospitals: Thank you for your continued support of prostate cancer research in

More information

IMAGE-GUIDED RADIATION THERAPY

IMAGE-GUIDED RADIATION THERAPY IMAGE-GUIDED RADIATION THERAPY Your Single Source Oncology Solutions Provider Plan. Target. Treat. At Best NOMOS, we design products and solutions that help medical professionals treat a variety of cancers.

More information

Measurements of Size and Weight of Prostate by Means of Transrectal Ultrasonotomography

Measurements of Size and Weight of Prostate by Means of Transrectal Ultrasonotomography Tohoku J. exp. Med., 1974, 114, 277-285 Measurements of Size and Weight of Prostate by Means of Transrectal Ultrasonotomography HIROKI WATANABE, DAIROKU IGARI, YOSHIKATSU TANAHASHI, KAZUYA IIARADA and

More information

in 32%, T2c in 16% and T3 in 2% of patients.

in 32%, T2c in 16% and T3 in 2% of patients. BJUI Gleason 7 prostate cancer treated with lowdose-rate brachytherapy: lack of impact of primary Gleason pattern on biochemical failure Richard G. Stock, Joshua Berkowitz, Seth R. Blacksburg and Nelson

More information

Percent Gleason pattern 4 in stratifying the prognosis of patients with intermediate-risk prostate cancer

Percent Gleason pattern 4 in stratifying the prognosis of patients with intermediate-risk prostate cancer Review Article Percent Gleason pattern 4 in stratifying the prognosis of patients with intermediate-risk prostate cancer Meenal Sharma 1, Hiroshi Miyamoto 1,2,3 1 Department of Pathology and Laboratory

More information

Early outcomes of active surveillance for localized prostate cancer

Early outcomes of active surveillance for localized prostate cancer Original Article ACTIVE SURVEILLANCE FOR LOCALIZED PROSTATE CANCER HARDIE et al. Early outcomes of active surveillance for localized prostate cancer CLAIRE HARDIE, CHRIS PARKER, ANDREW NORMAN*, ROS EELES,

More information

or more transrectal ultrasonography (TRUS)-guided ng/ml and 39% if it was 20.0 ng/ml. of >10 ng/ml have prostate cancer [3], many other

or more transrectal ultrasonography (TRUS)-guided ng/ml and 39% if it was 20.0 ng/ml. of >10 ng/ml have prostate cancer [3], many other BJU International (1999), 83, 34 38 Elevated serum prostate specific antigen levels in conjunction with an initial prostatic biopsy negative for carcinoma: who should undergo a repeat biopsy? G.C. DURKAN

More information

Statistical techniques to evaluate the agreement degree of medicine measurements

Statistical techniques to evaluate the agreement degree of medicine measurements Statistical techniques to evaluate the agreement degree of medicine measurements Luís M. Grilo 1, Helena L. Grilo 2, António de Oliveira 3 1 lgrilo@ipt.pt, Mathematics Department, Polytechnic Institute

More information

Accuracy and validity of Kinetisense joint measures for cardinal movements, compared to current experimental and clinical gold standards.

Accuracy and validity of Kinetisense joint measures for cardinal movements, compared to current experimental and clinical gold standards. Accuracy and validity of Kinetisense joint measures for cardinal movements, compared to current experimental and clinical gold standards. Prepared by Engineering and Human Performance Lab Department of

More information

LDR prostate brachytherapy

LDR prostate brachytherapy LDR prostate brachytherapy Introduction Low dose rate (LDR) prostate brachytherapy is a modern, effective minimally invasive treatment appropriate for many men with early prostate cancer. I perform this

More information

Multicenter Comparison of Four Automated Immunoassay Analyzers for Prostate Specific Antigen

Multicenter Comparison of Four Automated Immunoassay Analyzers for Prostate Specific Antigen Letter to the Editor Clinical Chemistry Ann Lab Med 19;39:6-41 https://doi.org/1.3343/alm.19.39.4.6 ISSN 2234-36 eissn 2234-3814 Multicenter Comparison of Four Automated Immunoassay Analyzers for Prostate

More information

It is time to abandon transrectal prostate biopsy for perineal biopsy. Con Argument

It is time to abandon transrectal prostate biopsy for perineal biopsy. Con Argument It is time to abandon transrectal prostate biopsy for perineal biopsy Con Argument Erik P. Castle M.D., F.A.C.S. Professor of Urology Mayo Clinic Department of Urology Phoenix, AZ None Financial Disclosures

More information

The Paul Evans Memorial Lecture Functional radiotherapy targeting using focused dose escalation. Roberto Alonzi Mount Vernon Cancer Centre

The Paul Evans Memorial Lecture Functional radiotherapy targeting using focused dose escalation. Roberto Alonzi Mount Vernon Cancer Centre The Paul Evans Memorial Lecture Functional radiotherapy targeting using focused dose escalation Roberto Alonzi Mount Vernon Cancer Centre Overview Introduction and rationale for focused dose escalation

More information

In 2005, International Society of Urological Pathology

In 2005, International Society of Urological Pathology ORIGINAL ARTICLE Gleason Score 3+4=7 Prostate Cancer With Minimal Quantity of Gleason Pattern 4 on Needle Biopsy Is Associated With Low-risk Tumor in Radical Prostatectomy Specimen Cheng Cheng Huang, MD,*

More information

Guide to Pelvic Floor Multicompartment Scanning

Guide to Pelvic Floor Multicompartment Scanning Guide to Pelvic Floor Multicompartment Scanning These guidelines have been prepared by Giulio A. Santoro, MD, PhD, Head Pelvic Floor Unit, Section of Anal Physiology and Ultrasound, Coloproctology Service,

More information

Classifying Breast Masses in Volumetric Whole Breast Ultrasound Data: A 2.5-Dimensional Approach

Classifying Breast Masses in Volumetric Whole Breast Ultrasound Data: A 2.5-Dimensional Approach Classifying Breast Masses in Volumetric Whole Breast Ultrasound Data: A 2.5-Dimensional Approach Gobert N. Lee 1,*, Toshiaki Okada 2, Daisuke Fukuoka 3, Chisako Muramatsu 2, Takeshi Hara 2, Takako Morita

More information

7 Grip aperture and target shape

7 Grip aperture and target shape 7 Grip aperture and target shape Based on: Verheij R, Brenner E, Smeets JBJ. The influence of target object shape on maximum grip aperture in human grasping movements. Exp Brain Res, In revision 103 Introduction

More information

CIC Edizioni Internazionali. MRI scans do not accurately predict hamstring graft diameter for ACL reconstruction. Original article.

CIC Edizioni Internazionali. MRI scans do not accurately predict hamstring graft diameter for ACL reconstruction. Original article. Ricci Plastow Clare Cullen Herbert Imalingat Jamie C Sergeant Neil Jain North Manchester Hospital, Manchester, UK Corresponding author: Ricci Plastow North Manchester Hospital, Delaunays Road, M8 5RB Manchester,

More information

Real-time brachytherapy for prostate cancer implant analysis

Real-time brachytherapy for prostate cancer implant analysis Rep Pract Oncol Radiother, 2008; 13(1): 9-14 Original Paper Received: 2007.04.17 Accepted: 2008.02.07 Published: 2008.02.29 Authors Contribution: A Study Design B Data Collection C Statistical Analysis

More information

NIH Public Access Author Manuscript World J Urol. Author manuscript; available in PMC 2012 February 1.

NIH Public Access Author Manuscript World J Urol. Author manuscript; available in PMC 2012 February 1. NIH Public Access Author Manuscript Published in final edited form as: World J Urol. 2011 February ; 29(1): 11 14. doi:10.1007/s00345-010-0625-4. Significance of preoperative PSA velocity in men with low

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Intensity-Modulated Radiation Therapy (IMRT) of the Prostate File Name: Origination: Last CAP Review: Next CAP Review: Last Review: intensity_modulated_radiation_therapy_imrt_of_the_prostate

More information

Upgrading and upstaging in prostate cancer: From prostate biopsy to radical prostatectomy

Upgrading and upstaging in prostate cancer: From prostate biopsy to radical prostatectomy MOLECULAR AND CLINICAL ONCOLOGY 2: 1145-1149 Upgrading and upstaging in prostate cancer: From prostate biopsy to radical prostatectomy CAROLINA D'ELIA, MARIA ANGELA CERRUTO, ANTONIO CIOFFI, GIOVANNI NOVELLA,

More information

Systems Pathology in Prostate Cancer

Systems Pathology in Prostate Cancer Systems Pathology in Prostate Cancer Policy Number: 2.04.64 Last Review: 8/2014 Origination: 8/2010 Next Review: 8/2015 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will not provide coverage

More information

Samantha McGlone B.Ed., Gabby Rabadam, Veronica Young Gurtej Grewal, Ph.D, Bijan Najafi PhD, Daniel Latt, M.D.,Ph.D Human Movement Biomechanics

Samantha McGlone B.Ed., Gabby Rabadam, Veronica Young Gurtej Grewal, Ph.D, Bijan Najafi PhD, Daniel Latt, M.D.,Ph.D Human Movement Biomechanics Samantha McGlone B.Ed., Gabby Rabadam, Veronica Young Gurtej Grewal, Ph.D, Bijan Najafi PhD, Daniel Latt, M.D.,Ph.D Human Movement Biomechanics Laboratory, icamp, University of Arizona Comparison of Three

More information

Likelihood of Prostate Cancer Based on Prostate-Specific Antigen Density by MRI: Retrospective Analysis

Likelihood of Prostate Cancer Based on Prostate-Specific Antigen Density by MRI: Retrospective Analysis Journal of Computer Assisted Tomography 26(3):432 437 2002 Lippincott Williams & Wilkins, Inc., Philadelphia Likelihood of Prostate Cancer Based on Prostate-Specific Antigen Density by MRI: Retrospective

More information